Deprecated: mysql_pconnect(): The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /home/dcz25x0vfkvf/public_html/Connections/bscon1.php on line 9


219 Mannose impairs tumour growth and enhances chemotherapy.

218 Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.

217 CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma.

216 Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.

215 Enhanced detection of circulating tumor DNA by fragment size analysis.

214 Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

213 Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

212 Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.

211 Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

210 Prediction of acute myeloid leukaemia risk in healthy individuals.

209 Cancer prevalence among flight attendants compared to the general population.

208 Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

207 Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer.

206 Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.

205 Higher Lung Cancer Incidence in Young Women Than Young Men in the United States.

204 Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

203 Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis.

202 Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

201 Analyses of genomes from 914 children, adolescents, and young adults provide a comprehensive resource of genomic alterations across a spectrum of common childhood cancers.

200 Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.

199 Detection and localization of surgically resectable cancers with a multi-analyte blood test.

198 Contemporary Hormonal Contraception and the Risk of Breast Cancer.

197 Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib.

196 Lomustine and Bevacizumab in Progressive Glioblastoma.

195 Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer.

194 Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study.

193 Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.

192 Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

191 Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

190 Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.

189 Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.

188 Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer.

187 Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

186 Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.

185 Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.

184 An immunogenic personal neoantigen vaccine for patients with melanoma.

183 Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.

182 Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.

181 Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

180 Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up.

Free Images for Presentation: sunipix SUNIPIX